Clinical Trial Update: Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

View source ↗

Summary

This clinical trial update reports observed outcomes from a completed study comparing the inhaled corticosteroid–long-acting beta-agonist combination fluticason…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Propionate/Salmeterol Xinafoate (fluticasone propionate/salmeterol xinafoate)
• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Status: COMPLETED